EP2707015
LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.5.2012EP published:
9.11.2016EP application number:
12721268.6
EPO information:
European Patent Register
Max expiry date:
10.5.2032
Title:
LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES
Timeline
Today
11.5.2012EP application
9.11.2016EP Publication
Owner
Name:
Sanofi-Aventis Deutschland GmbHAddress:
Brüningstraße 50, 65929, Frankfurt am Main, DE
Inventor
Name:
NIEMÖLLER, ElisabethAddress:
Frankfurt am Main, DE
Name:
SILVESTRE, LouiseAddress:
Paris, FR
Name:
BOKA, GaborAddress:
Paris, FR
Name:
MIOSSEC, PatrickAddress:
Paris, FR
Priority
Number:
11166111Date:
13.5.2011Country:
EP
Classification
Categories:
A61K 38/26, A61K 38/28, A61K 31/155, A61P 3/10, A61P 3/04